Symbol | Company | Owner | Relationship | Date | Transaction | Cost | # Shares | Value ($) | Total Shares | Filing | |
---|---|---|---|---|---|---|---|---|---|---|---|
ABBV | AbbVie Inc. | SEVERINO MICHAEL | Vice Chairman | May 23, 2022 | Option Exercise | $129.94 | 159,602 | 20,739,407 | 231,904 | May 25, 2022, 04:58 PM | |
ABBV | AbbVie Inc. | SEVERINO MICHAEL | Vice Chairman | May 16, 2022 | Sale | $110.48 | 200,000 | 22,095,365 | 252,103 | May 18, 2022, 05:12 PM | |
ABBV | AbbVie Inc. | SEVERINO MICHAEL | Vice Chairman | May 17, 2022 | Sale | $121.21 | 200,000 | 24,242,329 | 252,103 | May 18, 2022, 05:12 PM | |
ABBV | AbbVie Inc. | SEVERINO MICHAEL | Vice Chairman | May 09, 2022 | Sale | $103.25 | 200,000 | 20,649,188 | 252,103 | May 10, 2022, 05:05 PM | |
ABBV | AbbVie Inc. | SEVERINO MICHAEL | Vice Chairman | May 10, 2022 | Sale | $105.94 | 200,000 | 21,188,434 | 252,103 | May 10, 2022, 05:05 PM | |
ABBV | AbbVie Inc. | SEVERINO MICHAEL | Vice Chairman | May 06, 2022 | Sale | $102.68 | 200,000 | 20,535,403 | 252,103 | May 10, 2022, 05:05 PM | |
ABBV | AbbVie Inc. | SEVERINO MICHAEL | Vice Chairman | Feb 25, 2022 | Option Exercise | $149.54 | 38,857 | 5,810,676 | 152,103 | Mar 01, 2022, 06:08 PM | |
ABBV | AbbVie Inc. | SEVERINO MICHAEL | Vice Chairman | Feb 28, 2021 | Option Exercise | $107.74 | 29,077 | 3,132,756 | 103,835 | Mar 02, 2021, 08:26 PM | |
ABBV | AbbVie Inc. | SEVERINO MICHAEL | Vice Chairman | Nov 04, 2020 | Sale | $93.61 | 90,679 | 8,488,461 | 67,281 | Nov 06, 2020, 04:29 PM | |
ABBV | AbbVie Inc. | SEVERINO MICHAEL | Vice Chairman | Feb 28, 2020 | Option Exercise | $85.42 | 33,492 | 2,860,887 | 157,960 | Mar 03, 2020, 12:00 AM | |
ABBV | AbbVie Inc. | SEVERINO MICHAEL | Vice Chairman | Feb 28, 2019 | Option Exercise | $79.41 | 26,710 | 2,121,041 | 115,857 | Mar 04, 2019, 04:59 PM | |
ABBV | AbbVie Inc. | SEVERINO MICHAEL | EVP, R&D and CSO | Aug 17, 2018 | Sale | $97.52 | 50,000 | 4,876,060 | 111,481 | Aug 21, 2018, 04:58 PM | |
ABBV | AbbVie Inc. | SEVERINO MICHAEL | EVP, R&D and CSO | Feb 28, 2018 | Option Exercise | $118.23 | 30,326 | 3,585,475 | 134,924 | Mar 02, 2018, 05:30 PM | |
ABBV | AbbVie Inc. | SEVERINO MICHAEL | EVP, R&D and CSO | Nov 10, 2017 | Sale | $94.69 | 25,633 | 2,427,212 | 114,922 | Nov 13, 2017, 05:26 PM | |
ABBV | AbbVie Inc. | SEVERINO MICHAEL | EVP, R&D and CSO | Jun 02, 2017 | Option Exercise | $66.71 | 21,576 | 1,439,335 | 140,555 | Jun 05, 2017, 05:04 PM | |
ABBV | AbbVie Inc. | SEVERINO MICHAEL | EVP, R&D and CSO | Feb 28, 2017 | Option Exercise | $62.22 | 30,699 | 1,910,092 | 162,131 | Mar 02, 2017, 06:14 PM | |
ABBV | AbbVie Inc. | SEVERINO MICHAEL | EVP, R&D and CSO | Jun 02, 2016 | Option Exercise | $62.83 | 21,574 | 1,355,494 | 143,282 | Jun 03, 2016, 05:27 PM | |
ABBV | AbbVie Inc. | SEVERINO MICHAEL | EVP, R&D and CSO | Feb 29, 2016 | Option Exercise | $56.00 | 8,053 | 450,968 | 164,856 | Mar 02, 2016, 05:26 PM | |
ABBV | AbbVie Inc. | SEVERINO MICHAEL | EVP, R&D and CSO | Jun 02, 2015 | Option Exercise | $66.93 | 21,576 | 1,444,082 | 172,909 | Jun 04, 2015, 05:37 PM |